CBD Derived From Hemp Has Potential to Fight Ovarian Cancer Studies Find | CashCropToday
0 Shares 142 Views

CBD Derived From Hemp Has Potential to Fight Ovarian Cancer Studies Find

April 26, 2018
142 Views

Sara Biela and Chase Turner, graduate students from Sullivan University College of Pharmacy in Kentucky, presented new findings tied to industrial hemp derived CBD’s anti-cancer properties at the American Society for Biochemistry and Molecular Biology held back on April 21-25.


Link to the scientific studies


The two new studies investigated the potential for Cannabidiol (CBD) derived from a variety of hemp plant known as KY-hemp, grown and produced in Kentucky. Development of the new strain involved carefully growing the industrial hemp in an controlled environment in order to eliminate any residual contaminates that could possibly effect the therapeutic properties of the CBD that was extracted.

The first study researchers found that by adding a variety of different CBD doses to ovarian cells led to a slowing of cell migration, or metastasis. This would reduce the spread of cancer cells to other parts of the body. The second study, showed that the Ky-hemp variety slowed the “secretion of interleukin IL-1beta, which has been linked to slowing the ovarian cancer from spreading so quickly.

“Our findings from this research as well as prior research show that KY hemp slows ovarian cancer comparable to or even better than the current ovarian cancer drug Cisplatin,” said Turner. “Since Cisplatin exhibits high toxicity, we anticipate that hemp would carry less side effects. However, that needed to be tested in the future.

You may be interested

MJardin Group Announces CSE Listing and GrowForce Acquisition
Market Watch
11 views
Market Watch
11 views

MJardin Group Announces CSE Listing and GrowForce Acquisition

Editor - November 16, 2018

MJardin Group, Inc. (CSE: MJAR) announced earlier this week that the company will begin trading the company’s common stock on the Canadian Securities Exchange, under the ticket…

Invictus Strategies Corp. to Acquire GTEC Holdings in Exchange for $100M in Stock
Market Watch
18 views
Market Watch
18 views

Invictus Strategies Corp. to Acquire GTEC Holdings in Exchange for $100M in Stock

Editor - November 16, 2018

Invictus Strategies Corp. (TSXV: GENE) (OTCQX: IVITF) has announced this morning that the company has entered into an agreement to acquire GTEC Holdings Ltd. (TSXV: GTEC) (OTC:…

Columbia Care Receives Licenses from Maltese Government
Global
54 views
Global
54 views

Columbia Care Receives Licenses from Maltese Government

Editor - November 15, 2018

Columbia Care LLC. has announced this morning that the company has gain approval from Malta Enterprises, the regulatory economic development agency in the country, to receive licenses…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: